Artificial Intelligence

A new alliance between UltraGreen and LifeSignals will bring advanced wearable heart monitors to a global market, tackling rising cardiovascular disease.

A 3-year study of COVID survivors reveals a startling new risk: late-onset cognitive impairment, pushing for a radical shift in long-term brain monitoring.

German tech firm steute buys Minnesota's Electro-Sensors at a 75% premium, signaling a strategic push into the booming US industrial sensor market.

With a new CEO known for billion-dollar deals, Modulari-T Biosciences is poised to commercialize its next-gen in vivo cell therapy platform.

The medtech giant posts Q1 growth and secures critical EU approvals for new devices, navigating post-pandemic shifts and geopolitical headwinds with strong cash flow.

For the first time, Leica Gallery joins the art world's elite at AIPAD, showcasing 13 photographers and blurring the lines between brand and gallery.

The quant firm's AI-driven event strategy lands a key institutional partner, filling half of its $1B capacity and signaling a broader Wall Street shift.

A new platform uses the MCP open standard to let AI tools like ChatGPT securely analyze sensitive client data, aiming to transform advisor productivity.

Protos Security's latest acquisition signals a major industry shift, combining nationwide guarding with elite global intelligence and executive protection.

Rasa's recognition as a Strong Performer in a key Forrester Wave report highlights a growing enterprise demand for AI with data sovereignty and developer control.

Leaders converge at Menus of Change to tackle the 2035 food system, focusing on AI, blue foods, and business resilience for a sustainable future.

TradeZing launches TradeZ, an AI copilot for retail investors, promising one-tap trading and a unique accuracy score to cut through market noise.

With a $30M+ boost and a public market debut, Ionetix aims to scale its cyclotron tech for cancer therapy, diagnostics, and future energy solutions.

Pro-Vision is the first fleet video provider to achieve full team MECP certification, raising the bar for installation quality and system reliability.

New Operational AI tools automate no-show recovery and critical follow-ups, promising to reduce staff burnout and ensure patients no longer fall through the cracks.

A new liquid biopsy using viral DNA gets FDA fast-track status, promising to detect liver cancer recurrence more than five months earlier than imaging scans.

With the appointment of Mike Cavan, Quest Analytics signals a major push to dominate the provider network space by leveraging deep data analytics expertise.

A UK biotech's Rincell-1 therapy enters human trials, aiming to regenerate auditory nerves and restore hearing where current technology falls short.

With £21M in funding, new Focused Research Organizations, Meridial and Echo Labs, aim to tackle major bottlenecks in neuroscience and ecological intelligence.

UnitedHealth Group posted strong Q1 earnings but is shedding members in a bold pivot, divesting globally to double down on US-based AI and tech innovation.